Tess Lin

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Michael J. Morris, Steven P. Rowe, Michael A. Gorin et al. · Clinical Cancer Research · 2021 · 380 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with ¹⁸ F-DCFPyL in Prostate Cancer Patients (OSPREY)

Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe et al. · The Journal of Urology · 2021 · 372 citations · Full text

Medicine, Oncology, Radiology +17

Efficacy and Safety of High-Specific-Activity ¹³¹I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

Daniel A. Pryma, Bennett B. Chin, Richard B. Noto et al. · Journal of Nuclear Medicine · 2018 · 283 citations · Full text

Medicine, Oncology, Pharmacology +8

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma

Richard B. Noto, Daniel A. Pryma, Jessica Jensen et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 65 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY

Steven P. Rowe, Michael A. Gorin, Kenneth J. Pienta et al. · 2019 · 19 citations

Medicine, Nuclear Medicine, Radiology +17